Related Experiment Video

Updated: May 8, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Bardet-Biedl syndrome a rare cause of cardiomyopathy

Dinesh Kumar Yadav1, Mukesh Kumar Beniwal, Aditi Jain

  • 1Division of Pediatric Cardiology, Department of Neonatology and Pediatric Medicine, PGIMER, Dr. RML Hospital, New Delhi, India. dineshkumar169@yahoo.co.in

Indian Pediatrics
|August 15, 2013
PubMed

Insights

Bardet-Biedl syndrome (BBS), a rare genetic disorder, can present with cardiomyopathy. This case highlights the importance of considering BBS in patients with cardiac issues and other characteristic symptoms.

Area of Science:

  • Genetics
  • Cardiology
  • Rare Diseases

Background:

  • Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder.
  • Key features include retinitis pigmentosa, polydactyly, obesity, learning disabilities, hypogonadism, and renal anomalies.
  • Cardiomyopathy is an uncommon but reported manifestation of BBS.

Observation:

  • This report details a patient presenting with symptoms of cardiomyopathy.
  • The patient's clinical presentation prompted further investigation.
  • Diagnostic workup led to a subsequent diagnosis of BBS.

Findings:

  • The patient was diagnosed with Bardet-Biedl syndrome.
  • This case adds to the limited literature on cardiomyopathy in BBS.
  • The findings underscore a potential association between cardiac dysfunction and BBS.

Implications:

  • Recognizing cardiomyopathy as a potential BBS feature is crucial for early diagnosis.
  • This case may prompt further research into the cardiac manifestations of BBS.
  • Improved understanding can lead to better patient management and outcomes for BBS patients.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pedigree Analysis01:35

Pedigree Analysis

Overview